TwinStrand Biosciences
TwinStrand Biosciences develops Duplex Sequencing technology that uses error-corrected DNA sequencing to detect ultra-low-frequency genomic variants missed by conventional next-generation sequencing. Its technology supports researchers studying applications such as residual cancer, mutation signatures and genetic toxicology, with the aim of improving human health and accelerating scientific discovery.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2016 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 51–200
- Registered name
- TwinStrand Biosciences Inc Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Elon Musk's Starlink swagger, SpaceX vs. the cloud giants, and Seattle’s tech universe revisited
This week: SpaceX reports its first quarter as a public company, and Elon Musk says Starlink could deliver a majority of the world's internet within a decade, leveraging production facilities in Redmond. Musk also explains the company's data center ambitions, calling terrestrial infrastructure a trivial problem next to reusable rockets. Plus: we bring two Washington tech universe posters into the studio, 17 years apart. The 2009 original turns up gems including Boeing's unlikely connection to Classmates.com, a 1990s forerunner to Facebook. The 2009 poster also brings back memories of Teledesic, the Craig McCaw venture backed by Bill Gates that tried…
People
-
Jesse Salk Co-founder and CEO -
Ron Andrews Executive, Chief Executive Officer and Director